Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10301395 Chemically-locked bispecific antibodies

Patent 10301395 was granted and assigned to Sorrento Therapeutics on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Sorrento Therapeutics

Current Assignee

Sorrento Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103013950

Patent Inventor Names

Yanwen Fu0

Gunnar F. Kaufmann0

James T. Patterson0

Date of Patent

May 28, 2019

Patent Application Number

153539790

Date Filed

November 17, 2016

Patent Citations Received

‌

US Patent 11780922 Bifunctional proteins combining checkpoint blockade for targeted therapy

‌

US Patent 10799598 Disulfide bridging conjugates

‌

US Patent 11267905 Chemically-locked bispecific antibodies

Patent Primary Examiner

‌

Sheela J. Huff

Patent abstract

Provided are bispecific antibody compounds having the Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10301395 Chemically-locked bispecific antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API